Precision Business Insights has published a report on the global liquid biopsy market, estimating its value at USD 1,342.5 Million in 2025 and is expected to expand at a compound annual growth rate (CAGR) of 22.2% over the forecast period 2026-2032. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.

View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/liquid-biopsy-market

Market Definition:

By examining biomarkers (such as circulating tumor DNA, circulating tumor cells, or exosomes) in bodily fluids, primarily blood, liquid biopsy is a non-invasive diagnostic procedure that can identify cancer and other illnesses. Liquid biopsies, in contrast to conventional tissue biopsies, provide low-risk real-time monitoring of disease development and therapy response.

Drivers:

1) Rising Cancer Incidence Worldwide.
2) Demand for Non-Invasive Diagnostics.

The global liquid biopsy market segmentation:

1) By Product Type: Consumables, Instruments.
2) By Application Type: Blood, Urine Others.
3) By Sample Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer Others.
4) By End User: Hospitals, Diagnostic Laboratories, Academic and Research Centers Others.

Regional Overview:
The report also examines the current concerns and their Future Effects on the liquid biopsy market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the liquid biopsy market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.

·         North America (U.S., Canada)

·         Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)

·         Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)

·         Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)

·         Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

The competitive landscape is dominated by major players like Guardant Health | Foundation Medicine | Illumina | Roche | Thermo Fisher Scientific | Qiagen | Bio-Rad Laboratories | Exact Sciences | Natera | Myriad Genetics, NeoGenomics | Biocept | Freenome | Grail | Personal Genome Diagnostics | Adaptive Biotechnologies | Angle plc | Menarini Silicon Biosystems | Epic Sciences | Fluxion Biosciences, Rarecells Diagnostics | Cynvenio Biosystems | Exosome Diagnostics | Bio-Techne | Sysmex | Hitachi Chemical Diagnostics | Fujirebio | Hologic | Agilent Technologies | PerkinElmer, MDxHealth | Oncocyte | Genomic Health | Invitae | Biodesix | Caris Life Sciences | Tempus | Strand Life Sciences | MedGenome | Mapmygenome, Centogene | Burning Rock Biotech | BGI Genomics | Singlera Genomics | Berry Oncology | AnchorDx | Genetron Health | Amoy Diagnostics | Predicine | Guardant Health Asia

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747